Gold and silver hit the brakes after a jaw-dropping run, marking an abrupt halt in the precious metals frenzy. Folks, it was quite the spectacle.

So, gold futures? They took a nosedive, dropping 4.5% to just north of $4,340 per troy ounce. Silver futures weren’t having a great day either, tumbling nearly 8%—their worst since 2021—after a brief flirt with $80 per ounce.

Now, here’s the scoop. Traders were practically biting their nails ahead of Monday’s session. Why? Because the Chicago Mercantile Exchange decided to hike margin requirements on silver futures. That left highly leveraged traders scrambling to throw in more cash or say goodbye to their positions.

On top of everything, China, the silver mining giant, talked about slamming the brakes on exports come January. Bad timing, considering everyone’s racing to supply the ever-hungry AI industry with silver.

And who’s chiming in? None other than Elon Musk. He took to X, saying, “This is not good. Silver is needed in many industrial processes.” Can’t say he’s wrong.

Nearly 60% of all silver ends up in industrial applications, says the Silver Institute. It’s that hero conductor of electricity, essential for solar panels, server boards, and those electric cars you’ll see zipping around the streets.

Michael DiRienzo, the president and CEO of the Silver Institute, mentioned to Yahoo Finance, “It’s vital for electronics and computing. It’s used in almost everything that has an on and off switch.”

Interestingly, silver’s now in its fifth year of a global structural market deficit. In October, it landed a spot on the US critical minerals list. Some folks are fretting it might lead to tariffs and trade hurdles. Ain’t that a kicker?

This year, precious metals have been the talk of the town. Gold shot up 67% year to date, thanks to big-time central bank buys and a mellowing dollar. But silver? That’s the star here, with a staggering rally of nearly 150%, spotlighting those supply crunch issues. Even copper and platinum are joining the party, setting new records.

But here’s a word from the wise: Mike McGlone, a senior commodity strategist at Bloomberg Intelligence, has been throwing up caution flags. Said the last time gold and silver took off like this was in 1979. Prices hit their peak in 1980 and then crashed faster than yesterday’s commuter train.

McGlone advises, “When it gets this stretched, be careful.” His mantra for the gold-loving crowd is simply, “Take profits.”

For more on these market shenanigans, follow Ines Ferre, a senior business reporter, on X at @ines_ferre.

Dive deeper into today’s market scene here.

And if you’re pondering about getting your hands on some gold, check out our guide on how to invest in gold in 4 steps.

The post Exercise Caution When It Reaches This Limit appeared first on Kingston Global Tokyo Japan.

Uber Faces the FTC Heat

14 minutes ago

Uber Disrupted
Uber’s stock took a hit on Monday—down a cool 3%—with the FTC bringing the heat. The lawsuit allegedly targets the ride-hailing behemoth’s sleazy billing and cancellation moves related to Uber One. The $9.99 monthly subscription supposedly plays hard-to-get when users try to quit.

The lawsuit claims Uber pulls a fast one with tiny gray text that customers overlook, enrolling them without consent. Promised savings? They’re ghosting users, allegedly. The ride-share colossus isn’t backing down, with a spokesperson promising that the courts will see it their way. This action, though, puts a spotlight on the pitfalls of snagging a deal that promises a 6% back on rides—legal wrangling sounds like such a bother.

AND yet, even with this bump in the road, Uber’s stock is still up a whopping 20% this year. Guess we’ll see how things shake out on May 7, when first-quarter earnings join the scene.

Gold Rides High

1 hr 39 min ago

Chaos Loves Gold
Gold’s got the glow. Monday saw prices skyrocket as worries about the U.S.-China tango and Trump’s Federal Reserve shade continue to cast an uncertain econ vibe. Gold futures ascended to north of $3,440, a figure that adds a hearty 30% rise for the year.

Traders are jittery, and not just from coffee. Trump’s tariff tiffs have sent stock-slingers rushing into golden arms. Gold’s been the toast of the asset world, lapping up inflows only matched by Bitcoin’s ups and downs. With the safe-haven variance index peaking, the gold fever isn’t cooling anytime soon.

Tariff Talkers
China popping off about retaliatory dances makes investors more skittish than a cat in a dog park. The threat of Trump ousting Fed Chair Powell isn’t helping things either.

Amazon Feels The Tariff Crunch

2 hr 13 min ago

Analysts Play Hardball
Wall Street juggernaut Amazon got dinged on Monday. Raymond James analysts dropped Amazon from “strong buy” like a hot potato, tagging it “outperform” instead. Their price target? Slashed by almost 30%, taking a swing from $248 to $195.

Shadow Boxing
It’s all thanks to tariffs and those tricky investments in trying to make rural deliveries happen. Analysts suggest the media monolith should’ve read the room a bit better. Stocks have tumbled 4% to around $166 without breaking a sweat, surpassing the Nasdaq Composite’s decline this year.

Dollar And Its Doldrums

2 hr 41 min ago

Slumpy Dollar Days
The dollar took a nosedive. President Trump’s unyielding spat with Fed Chair Powell, whose ‘termination’ can’t come fast enough according to Trump, has set tongues wagging and metrics sagging. Investors are skirting dollar-based assets and diving into gold’s allure instead. The benchmark dollar index, DXY, dipped to levels not seen in over three years.

Intel’s New Chapter

3 hr 32 min ago

Eyes on Intel
Lip-Bu Tan, Intel’s new head honcho, is sweating under the spotlight this Thursday. It’s his debut earnings report, and analysts have their pens poised. With promises of deals in the air, a recent 51% stake sale in Altera, and murmurings of a TSMC tie-up, Tan’s got his hands full.

But for Intel investors, patience isn’t just a virtue—it’s the whole playbook. The stock, despite being less than $19 last week, has traders and analysts holding their breath.

Tesla’s Bumpy Ride

4 hr 39 min ago

Elon Musk Drama
Tesla partisans are sweat-soaked. Dan Ives warns Tesla’s got a big headache coming—Musk’s government gig is clogging the gears. He needs to ditch the bureaucratic monkey suit and throw himself back into Tesla’s driver’s seat.

Long-time bullish Ives is watching from the wings as Musk juggles too many ball caps, but his ‘code red situation’ alert is lighting up the status board.

Capital One and Discover’s Big Play

5 hr 15 min ago

Credit Card Shuffle
Shares of Capital One and Discover are getting a love boost. The merger train is leaving the station, thanks to federal regulators giving their thumb’s up. This planned multibillion-dollar union aims to dominate the credit card scene, perhaps reshaping the financial marketplace.

The Federal Reserve and Office of the Comptroller of the Currency are onboard. The Justice Department said, ‘no interference from us.’ The relief is palpable.

Nvidia and Trade Woes

6 hr 20 min ago

Chipmaker Challenges
Nvidia takes a hit as the game of tariff chess plays on between U.S. and China. CEO Jensen Huang speaks candidly; Trump’s tariffs are squeezing Nvidia. Those H20 chips need a license for any trip to China, which could mean a costly loss. The shares have taken a substantial tumble.

UnitedHealth’s Slog

6 hr 41 min ago

Profit Loss Pressures
UnitedHealth saw a slump with the worst decline in decades. Medical costs are pushing profits to the edge as the government-assisted Medicare plan demands more coverage. A market dive south of the 200-week average has let institutional investors show them the door.

Netflix: Before and After

7 hr 13 min ago

Streaming Success
Netflix’s stock is on the ups, courtesy of stout earnings. Analysts swapped in boost-city with stellar predictions. Watching their success in tougher climates has tongues wagging. They’ve made being ‘widely accessible’ work.

Market Vibes

7 hr 53 min ago

Staring into the Red
Major index futures signal Monday’s open as a downer. The Dow, S&P 500, and Nasdaq futures drop deeper into the red sea. Markets stay on the edge of their seats, trying to reclaim some semblance of direction.

The post Markets Decline Amid Trump’s Fed Criticism and Ongoing Tariff Worries; Gold Reaches New Peak, Dollar Falls to Lowest in 3 Years appeared first on Kingston Global Tokyo Japan.

Champions Oncology: Feeling Met Like the Big Apple

Champions Oncology, Inc. (NASDAQ: CSBR) has really stepped into the spotlight recently, hitting a fresh 52-week high at $9.94. With a market cap in the ballpark of $133 million and annual revenue of around $54 million, this biotech wonder is trading above its InvestingPro Fair Value. Tech indicators? They’re whispering ‘overbought,’ but let’s not get ahead of ourselves.

A Turnaround Tale

Flashback: the recent financial report for Q2 2024. Not only did Champions Oncology exceed earnings expectations, but they blew them out of the water. We’re talking earnings per share (EPS) of $0.05, leaving the forecasted -$0.03 in the dust. The revenue wasn’t just meeting a $13.32 million prediction, it strutted in at $13.5 million. That’s a notable turnaround, wouldn’t you say?

Numbers Doing the Talking

In the big picture, we’re looking at a 17% revenue increase year-over-year, tapping that $13.5 million mark. Champions flipped their previous year’s loss on its head, hitting a GAAP income of $700,000. All of this thanks to some savvy cost management and strategic focus on high-margin offerings. Now that’s how you do business in New York.

Analysts & Strategies: A Data-Driven Future

Hope glimmers on the horizon as Champions expects 10-15% revenue growth for fiscal 2025. During a recent earnings call, Craig Hallum’s analysts poked around about the company’s lofty plans to cash in on deep biological data sets. Both CEO Ronnie Morris and CFO David Miller were buzzing with optimism. They envisaged this data strategy as a game-changer, something that’ll position Champions Oncology as a transformative force in biotech. No more ‘under the radar’ for them!

Stock Trends & Market Impact

Reflecting on the past year, Champions Oncology’s stock has catapulted by 56.19%, with a stampede of momentum showing an 87.5% leap over the last six months. While the company is still not profitable, analysts have their crystal balls out. Many are projecting the joys of positive earnings this year.

According to InvestingPro, Champions Oncology comes with at least 12 key insights into financial health and market standing. It’s a company giving signals that it’s about to make a serious mark.

The Big Apple Forward

Champions Oncology, a New Yorker at heart, is navigating the hustle and bustle of the modern market with finesse. While AI and editors may have laid a digital hand on crafting this narrative, the essence rings true. For more, mix a coffee and stroll over to this link.

This isn’t just about a stock hitting a new high. It’s a New York story of resilience, strategy, and transformation. And trust me, that’s just how we like it around here.

The post CSBR Stock Reaches Annual Peak of $9.94 Due to Growth appeared first on Kingston Global Tokyo Japan.

Viad Corp’s stock hitting a fresh 52-week high is the talk of the town here. We’re seeing the shares waltz up to $45.71, a cool 39.07% jump in the past year. Investors seem to be betting big on Viad, their faith bolstered by the company’s strategic moves and sterling financial performance.

Viad’s Financial Performance doesn’t surprise the market squirrels. The firm posted enviable Q2 2024 earnings, outperforming predictions. Much credit goes to their GES and Pursuit sectors. Hints from Jill Bright joining the Board and Oppenheimer maintaining that ‘Outperform’ rating, only fans the flames of investor confidence.

Now, here’s a spicy nugget: Viad Corp’s unloading their GES business to Truelink Capital for a hefty $535 million. This isn’t just any transaction. It’s a tactical move paving the exit for GES, spotlighting Viad’s growing attractions and hospitality gig, Pursuit. After this high-profile sale, expect Viad to shed its old skin and be reborn, flaunting a shiny new “Pursuit” persona. David Barry, current head, is cued to rock the CEO and President hats post-sale.

Pursuit’s Bold Moves

Pursuit isn’t just lounging around. In a spectacular 2023, it hosted 3.5 million visitors, pocketing $350 million in revenue. And it seems they’ve no intention of hitting the brakes just yet. With a $20 million war chest set aside for 2024, Pursuit plans to expand through both organic growth and acquisitions. The Empire State of Mind demands big apple-sized ambitions, after all.

Viad’s recent prowess is deemed promising by InvestingPro Insights. The company has been riding on a strong tide with a solid 26.53% price return over three short months, culminating in an 11.01% uptick last week alone. Their insights even spill some coffee: an expected surge in net income this year.

Why Investors Might Keep Smiling

First up, Viad’s cruising with robust revenue growth — a tidy 17.1% bump over the last 12 months through Q3 2024. Impressive, sure, but what really tingles the spine is the 24.54% quarterly growth. Despite sporting a relatively high P/E ratio of 43.4, Viad’s 0.29 PEG ratio insinuates some hidden worth relative to its growth prospects.

Whole lotta numbers, right? But breathe easy, my friend. InvestingPro’s 12 further insights promise a port in this financial storm, allowing a more comprehensive dive into Viad’s fiscal health and stance in the market.

Whether you’re a Wall Street veteran or just climbing aboard, Viad Corp’s narrative is tantalizing — both in financial theater and strategic ballet. It’s a story echoing the ambition and grit that’s so palpable in the city that never sleeps.

This article was brewed with AI beans and polished by a human touch. Learn more in our Terms & Conditions.

The post Viad Corp Stock Reaches $45.71, Achieving Its Highest Point This Year appeared first on Kingston Global Tokyo Japan.